International Assets Investment Management LLC Boosts Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

International Assets Investment Management LLC raised its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 2,610.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,003 shares of the company’s stock after purchasing an additional 966 shares during the period. International Assets Investment Management LLC’s holdings in OrthoPediatrics were worth $27,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in KIDS. BNP Paribas Financial Markets boosted its stake in OrthoPediatrics by 85.1% during the first quarter. BNP Paribas Financial Markets now owns 12,414 shares of the company’s stock valued at $362,000 after buying an additional 5,707 shares during the period. Quantbot Technologies LP boosted its position in shares of OrthoPediatrics by 180.8% during the 1st quarter. Quantbot Technologies LP now owns 7,091 shares of the company’s stock valued at $207,000 after acquiring an additional 4,566 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new stake in shares of OrthoPediatrics during the 1st quarter valued at about $178,000. Vanguard Group Inc. grew its holdings in shares of OrthoPediatrics by 1.3% during the first quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock worth $25,772,000 after purchasing an additional 11,100 shares in the last quarter. Finally, EntryPoint Capital LLC increased its position in shares of OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after purchasing an additional 1,009 shares during the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

KIDS has been the subject of several research analyst reports. Truist Financial dropped their target price on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research report on Monday, October 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a report on Friday. Finally, JMP Securities reissued a “market outperform” rating and issued a $50.00 target price on shares of OrthoPediatrics in a research note on Friday, September 13th.

Insiders Place Their Bets

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the completion of the sale, the general counsel now owns 77,304 shares of the company’s stock, valued at approximately $2,265,007.20. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 31.80% of the company’s stock.

OrthoPediatrics Trading Down 6.4 %

NASDAQ:KIDS opened at $25.72 on Friday. The business has a 50 day moving average of $27.76 and a 200 day moving average of $29.81. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.96 and a current ratio of 4.90. OrthoPediatrics Corp. has a 1-year low of $24.02 and a 1-year high of $36.23.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.